ClearPoint Neuro Announces FDA Clearance for SmartFrame OR ™ Stereotactic System

SOLANA BEACH, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. CLPT (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has received 510(k) clearance for its SmartFrame OR™ Stereotactic…#solanabeach #mrandorct #clearpointer #clearpoint #joeburnett #clearpointneuro #robrubio #fda #southamerica #cns
Source: Reuters: Health - Category: Consumer Health News Source Type: news